tetano
Editor, Senior Moderator
J Community Hosp Intern Med Perspect
. 2024 Mar 4;14(2):30-39.
doi: 10.55729/2000-9666.1326. eCollection 2024. Outcomes of Upper Gastrointestinal Bleeding in Hospitalized COVID-19 Patients in the United States: A Propensity-score Matched Analysis of a Large National Database
Moon Ryu[SUP] 1 [/SUP], Mohammed Quazi[SUP] 2 [/SUP], Niloy Ghosh[SUP] 1 [/SUP], Karthik Gangu[SUP] 3 [/SUP], Amir H Sohail[SUP] 4 [/SUP], Asif Farooq[SUP] 5 [/SUP], Babu S Maringanti[SUP] 1 [/SUP], Aman Goyal[SUP] 6 [/SUP], Anupa Patel[SUP] 5 [/SUP], Muhammad S Khan[SUP] 7 [/SUP], Abu B Sheikh[SUP] 1 [/SUP]
Affiliations
Patients with cirrhosis that are hospitalized with COVID-19 infection have been found to have worse outcomes. No comparative study has been conducted between gastrointestinal (GI) bleeding in patients with cirrhosis who are diagnosed with COVID-19. We utilized the National Inpatient Sample (NIS) database to perform a retrospective analysis of 24, 050 patients diagnosed with cirrhosis and COVID-19. The identified patients were separated into variceal bleeding, nonvariceal bleeding, and no (or neither) GI bleeding groups. After performing propensity sample matching and multivariate analysis of mortality, we found no significant differences in mortality among the three groups. However, the variceal bleed group had a shorter length of stay (5.67 days lower than the no-bleed group). Esophagogastroduodenoscopy (EGD) with intervention was associated with reduced mortality in the variceal and nonvariceal bleeding groups. Acute kidney injury was a strong predictor of mortality in both bleeding groups. A native American race was found to be associated with higher mortality in the nonvariceal bleeding group. Our study suggests that there are various pathophysiological processes among the three groups, with no significant mortality differences with cirrhosis complications of GI bleeding.
Keywords: Acute kidney injury; Coronavirus disease; Esophageal varices; Gastrointestinal bleeding; Gastrointestinal complications; Liver cirrhosis.
. 2024 Mar 4;14(2):30-39.
doi: 10.55729/2000-9666.1326. eCollection 2024. Outcomes of Upper Gastrointestinal Bleeding in Hospitalized COVID-19 Patients in the United States: A Propensity-score Matched Analysis of a Large National Database
Moon Ryu[SUP] 1 [/SUP], Mohammed Quazi[SUP] 2 [/SUP], Niloy Ghosh[SUP] 1 [/SUP], Karthik Gangu[SUP] 3 [/SUP], Amir H Sohail[SUP] 4 [/SUP], Asif Farooq[SUP] 5 [/SUP], Babu S Maringanti[SUP] 1 [/SUP], Aman Goyal[SUP] 6 [/SUP], Anupa Patel[SUP] 5 [/SUP], Muhammad S Khan[SUP] 7 [/SUP], Abu B Sheikh[SUP] 1 [/SUP]
Affiliations
- PMID: 38966514
- PMCID: PMC11221441
- DOI: 10.55729/2000-9666.1326
Patients with cirrhosis that are hospitalized with COVID-19 infection have been found to have worse outcomes. No comparative study has been conducted between gastrointestinal (GI) bleeding in patients with cirrhosis who are diagnosed with COVID-19. We utilized the National Inpatient Sample (NIS) database to perform a retrospective analysis of 24, 050 patients diagnosed with cirrhosis and COVID-19. The identified patients were separated into variceal bleeding, nonvariceal bleeding, and no (or neither) GI bleeding groups. After performing propensity sample matching and multivariate analysis of mortality, we found no significant differences in mortality among the three groups. However, the variceal bleed group had a shorter length of stay (5.67 days lower than the no-bleed group). Esophagogastroduodenoscopy (EGD) with intervention was associated with reduced mortality in the variceal and nonvariceal bleeding groups. Acute kidney injury was a strong predictor of mortality in both bleeding groups. A native American race was found to be associated with higher mortality in the nonvariceal bleeding group. Our study suggests that there are various pathophysiological processes among the three groups, with no significant mortality differences with cirrhosis complications of GI bleeding.
Keywords: Acute kidney injury; Coronavirus disease; Esophageal varices; Gastrointestinal bleeding; Gastrointestinal complications; Liver cirrhosis.